CM Management’s Alkermes ALKS Stock Holding History

CM Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70,000	Closed	-$1.31M	–	86
2021 Q1	$1.31M	Buy	+70,000	New	+$1.43M	0.97%	36

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CM Management's ALKS Position: Q2 2021 in Review

CM Management sold out of Alkermes (ALKS) in Q2 2021, closing a stake of 70,000 shares — an estimated $1.31M sold.

CM Management first reported a position in ALKS in Q1 2021 and held it in 1 quarter. The position peaked at $1.31M in Q1 2021. 226 funds tracked by Wall St. Rank hold ALKS as of Q2 2021.

CM Management reported no remaining Alkermes position as of Q2 2021 after selling out during the quarter.
CM Management sold 70,000 Alkermes shares in Q2 2021, an estimated $1.31M.
CM Management first reported a position in Alkermes in Q1 2021 and held it in 1 quarter.
CM Management's Alkermes position peaked at $1.31M in Q1 2021.
226 funds tracked by Wall St. Rank held Alkermes as of Q2 2021.

Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.